These results hint that low serum and blood cord IGFBP-1 levels lead to an increase in IGF-1 bioavailability in GDM, probably due to the reduced phosphorylation of this binding protein observed in diabetes (84). This evidence concerns the gene IGFBP1 and gestational diabetes.